Through these established regional suppliers, Melt&Marble aims to give personal care manufacturers broader access to Marble7® and the support needed to evaluate it for new formulations.

EUROPE/ASIA/AUSTRALIA – Melt&Marble, a Swedish precision fermentation company, is expanding access to its bio-designed lipids for personal care manufacturers through new distribution partnerships across Europe, Asia, and Australasia.
The agreements will make it easier for manufacturers to source, assess, and incorporate Marble7®, the company’s first commercially available bioactive lipid ingredient, into their products.
The expanded network includes Eigenmann & Veronelli in Italy, Spain, Poland, and Turkey; Bionord across Scandinavia; Cornelius in the UK and Ireland; Lavollée in France; Seil in South Korea; and Ingredients Plus in Australia and New Zealand.
Dr Anastasia Krivoruchko, Co-founder and CEO of Melt&Marble, stated, “Developing high-performance ingredients is only part of the challenge. Manufacturers also need to be able to access them, evaluate them and ultimately integrate them into their products.”
“The personal care industry is highly fragmented, and these partnerships give us access to established customer networks, local market knowledge and technical expertise that would take years to build on our own. This is an important step toward bringing our ingredients to market at scale.”
Marble7® is a 3-in-1 bioactive lipid produced through precision fermentation, a process that enables fats and lipids to be created with targeted structural and performance characteristics.
Rich in omega-7 and designed for personal care use, it combines a biomimetic skin-lipid profile with structural stability and a smooth, melt-on-contact texture.
It offers formulators an alternative to conventional emollients in skincare, haircare, and makeup products.
Marble7® is designed to deliver three complementary functions: biomimetic care, structural performance, and a distinctive sensory experience.
Its omega-7-rich composition resembles human sebum, supporting skin, scalp, and hair-fiber care, while its structure contributes stability and luminosity to formulations.
The ingredient also melts at skin temperature, creating a solid-to-silk texture and silicone-like glide.
Marble7® received its International Nomenclature of Cosmetic Ingredients (INCI) name, r-Saccharomyces Butter, in March 2026 and was commercially launched in July 2026.
The expanded distribution network builds on that launch by helping manufacturers access the ingredient in their local markets, obtain samples, and receive technical documentation and formulation support.
The agreements represent another step in Melt&Marble’s commercial growth following its €7.3 million (USD 8.09 million) Series A financing round in December 2025.
The funding was raised to support production scale-up and the commercialization of the company’s first ingredients.
Across the personal care sector, manufacturers are increasingly seeking high-performance ingredients that combine functionality, sensory appeal, and more resilient sourcing.
Melt&Marble’s precision fermentation platform is designed to address these needs by enabling fats and lipids to be tailored for specific applications.
Sign up to receive our email newsletters with the latest news updates and insights from Africa and the World HERE.